Culture and psychedelic psychotherapy: Ethnic and racial themes from three Black women therapists
Monnica T. Williams, Sara Reed, Jamilah R. George
Journal of Evolutionary Psychology September 21, 2020 DOI: 10.1556/2054.2020.00137 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 3 |
| Population | African American female therapists |
| Interventions | 3 4-methylenedioxymethamphetamine (MDMA) |
| Duration | One-time use |
| Keywords | Facilitator Psychotherapist Mental health Racialization Ethnic group Oppression Clinical psychology |
| Citations | 62 |
| Key findings | The primary themes from the MDMA experiences of three African American female therapists were strength, safety, connection, and managing oppression/racialization, suggesting that Western models of psychedelic-assisted psychotherapy could be more effective and accessible to the Black community. |
Abstract
Abstract Psychedelic medicine is an emerging field of research and practice that examines the psychotherapeutic effects of substances classified as hallucinogens on the human mind, body, and spirit. Current research explores the safety and efficacy of these substances for mental health disorders including anxiety, depression, and posttraumatic stress disorder (PTSD). Although current studies explore psychotherapeutic effects from a biomedical perspective, gaps in awareness around cultural issues in the therapeutic process are prominent. African Americans have been absent from psychedelic research as both participants and researchers, and little attention has been paid to the potential of psychedelics to address traumas caused by racialization. This paper examines cultural themes and clinical applications from the one-time use of 3,4-methylenedioxymethamphetamine (MDMA) as part of an US Food and Drug Administration (FDA)-approved clinical trial and training exercise for three African American female therapists. The primary themes that emerged across the varied experiences centered on strength, safety, connection, and managing oppression/racialization. The participants' experiences were found to be personally meaningful and instructive for how Western models of psychedelic-assisted psychotherapy could be more effective and accessible to the Black community. Included is a discussion of the importance of facilitator training to make best use of emerging material when it includes cultural, racial, and spiritual themes. A lack of knowledge and epistemic humility can create barriers to treatment for underserved populations. Implications for future research and practice for marginalized cultural groups are also discussed, including consideration of Functional Analytic Psychotherapy (FAP) as an adjunct to the psychedelic-therapy approaches currently advanced. As women of color are among the most stigmatized groups of people, it is essential to incorporate their perspectives into the literature to expand conversations about health equity.
Citations in the library
Cited by 49
- Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression Frontiers in Pharmacology March 31, 2022
- Research abuses against people of colour and other vulnerable groups in early psychedelic research Journal of Medical Ethics July 12, 2021
- The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision Frontiers in Psychiatry January 20, 2022
- Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Journal of Palliative Medicine August 1, 2022
- Set and Setting in the Santo Daime Frontiers in Pharmacology May 4, 2021
and 44 more in the library
Cites 21
- A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression Archives of General Psychiatry August 1, 2006
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry May 1, 2018
- Psychedelics not linked to mental health problems or suicidal behavior: A population study Journal of Psychopharmacology March 1, 2015
- Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature BMC Psychiatry July 31, 2018
and 16 more in the library